IL1B and Insulin resistance: Consistent with LJ3402's suppression of circulating inflammatory cytokines (TNFα and IL‐1β), LJ3402 administration mitigated age‐related insulin resistance and impaired thermoregulation, as demonstrated by improved glucose and insulin tolerance and increased cold resistance.